Trade Edwards Lifesciences - EW CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 65.97 |
| Open | 66.64 |
| 1-Year Change | -12.15% |
| Day's Range | 65.45 - 66.88 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 6, 2024 | 66.76 | 0.83 | 1.26% | 65.93 | 66.97 | 65.38 |
| Sep 5, 2024 | 65.97 | -2.71 | -3.95% | 68.68 | 68.98 | 64.54 |
| Sep 4, 2024 | 68.75 | 0.36 | 0.53% | 68.39 | 69.84 | 68.14 |
| Sep 3, 2024 | 68.49 | -0.99 | -1.42% | 69.48 | 69.84 | 67.87 |
| Aug 30, 2024 | 69.91 | -0.19 | -0.27% | 70.10 | 71.04 | 69.53 |
| Aug 29, 2024 | 70.06 | 1.27 | 1.85% | 68.79 | 71.32 | 68.56 |
| Aug 28, 2024 | 68.54 | -0.78 | -1.13% | 69.32 | 69.52 | 68.28 |
| Aug 27, 2024 | 69.57 | 1.51 | 2.22% | 68.06 | 69.61 | 67.94 |
| Aug 26, 2024 | 68.69 | -1.74 | -2.47% | 70.43 | 70.74 | 68.60 |
| Aug 23, 2024 | 70.79 | -0.47 | -0.66% | 71.26 | 71.64 | 70.17 |
| Aug 22, 2024 | 71.24 | 0.96 | 1.37% | 70.28 | 71.65 | 70.28 |
| Aug 21, 2024 | 70.01 | 0.76 | 1.10% | 69.25 | 70.26 | 68.87 |
| Aug 20, 2024 | 69.32 | 1.25 | 1.84% | 68.07 | 70.13 | 68.07 |
| Aug 19, 2024 | 68.18 | -0.67 | -0.97% | 68.85 | 69.29 | 67.58 |
| Aug 16, 2024 | 68.85 | 0.90 | 1.32% | 67.95 | 69.27 | 67.79 |
| Aug 15, 2024 | 68.06 | 0.91 | 1.36% | 67.15 | 68.16 | 66.63 |
| Aug 14, 2024 | 66.42 | 0.32 | 0.48% | 66.10 | 66.62 | 65.46 |
| Aug 13, 2024 | 66.22 | 0.65 | 0.99% | 65.57 | 67.09 | 65.25 |
| Aug 12, 2024 | 65.47 | 0.96 | 1.49% | 64.51 | 65.49 | 64.15 |
| Aug 9, 2024 | 64.57 | 1.66 | 2.64% | 62.91 | 64.71 | 62.64 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Edwards Lifesciences Company profile
About Edwards Lifesciences Corp
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Edwards Lifesciences Corp revenues increased 19% to $5.23B. Net income increased 83% to $1.5B. Revenues reflect Transcatheter Aortic Valve Replacement segment increase of 20% to $3.42B, Surgical Heart Valve Therapy segment increase of 17% to $889.1M, Critical Care segment increase of 15% to $834.9M, United States segment increase of 18% to $2.96B, Europe segment increase of 26% to $1.19B.
Equity composition
Common Stock $1 Par, 12/10, 350M auth., 117,100,000 issd. less 2,000 shs. in Treas. @ $102M. Insiders control 0.64%. 4/3/00,Company spun off from Baxter International. 05/10, 2-for-1 stock split. 12/15, 2-for-1 stock split.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
One Edwards Way
IRVINE
CALIFORNIA 92614
US
News
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024
FOMC PREVIEW
Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.
14:09, 1 August 2024
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com